The Impact of Long-Acting Injectable vs Oral Antipsychotics on Hospitalization Rates in Patients with Schizophrenia: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Lafeuille, Marie-Helene [1 ]
Dean, Jason [1 ]
Carter, Valerie [1 ]
Duh, Mei Sheng [2 ]
Fastenau, John [3 ]
Dirani, Riad [3 ]
Lefebvre, Patrick [1 ]
机构：
[1] Grp Anal Ltee, Montreal, PQ, Canada
[2] Anal Grp Inc, Boston, MA USA
[3] Janssen Sci Affairs LLC, Titusville, NJ USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
515
引用
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [21] Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
    Dee Lin
    Philippe Thompson-Leduc
    Isabelle Ghelerter
    Ha Nguyen
    Marie-Hélène Lafeuille
    Carmela Benson
    Panagiotis Mavros
    Patrick Lefebvre
    CNS Drugs, 2021, 35 : 469 - 481
  • [22] Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients' subjective experiences
    Aprile, Sofia Francesca
    Rodolico, Alessandro
    Di Francesco, Antonio
    Varrasi, Sofia
    Bighelli, Irene
    Castellano, Sabrina
    Signorelli, Maria Salvina
    Leucht, Stefan
    Caraci, Filippo
    PSYCHIATRY RESEARCH, 2025, 348
  • [23] Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics
    Lin, Ching-Hua
    Chen, Feng-Chua
    Chan, Hung-Yu
    Hsu, Chun-Chi
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2019, 22 (09): : 541 - 547
  • [24] Preliminary results of a network meta-analysis on the efficacy of long-acting injectable antipsychotics in schizophrenia
    Medrano, R.
    Carranza, F.
    Saucedo, E.
    Guerrero, A.
    EUROPEAN PSYCHIATRY, 2021, 64 : S162 - S162
  • [25] Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
    Dee Lin
    Philippe Thompson-Leduc
    Isabelle Ghelerter
    Ha Nguyen
    Marie-Hélène Lafeuille
    Carmela Benson
    Panagiotis Mavros
    Patrick Lefebvre
    CNS Drugs, 2021, 35 : 923 - 923
  • [26] Long-acting injectable versus oral antipsychotics for schizophrenia reply
    Kishimoto, Taishiro
    Hagi, Katsuhiko
    Kurokawa, Shunya
    Kane, John M.
    Correll, Christoph U.
    LANCET PSYCHIATRY, 2021, 8 (07): : 567 - 567
  • [27] Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre?post studies
    Kishimoto, Taishiro
    Hagi, Katsuhiko
    Kurokawa, Shunya
    Kane, John M.
    Correll, Christoph U.
    LANCET PSYCHIATRY, 2021, 8 (05): : 387 - 404
  • [28] Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis
    Vita, Giovanni
    Tavella, Angelantonio
    Ostuzzi, Giovanni
    Tedeschi, Federico
    De Prisco, Michele
    Segarra, Rafael
    Solmi, Marco
    Barbui, Corrado
    Correll, Christoph U.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2024, 14
  • [29] Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations
    Zaniolo, Orietta
    Ghetti, Gianni
    Povero, Massimiliano
    Pradelli, Lorenzo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2019, 20 (01) : 12 - 23
  • [30] SYSTEMATIC REVIEW OF LONG-ACTING INJECTABLES (LAI) VERSUS ORAL ATYPICAL ANTIPSYCHOTICS (OA) ON HOSPITALIZATION IN SCHIZOPHRENIA
    Lafeuille, M. H.
    Cloutier, M.
    Fortier, J.
    Duh, M. S.
    Fastenau, J.
    Dirani, R.
    Lefebvre, P.
    VALUE IN HEALTH, 2014, 17 (03) : A210 - A210
12345